Project Grant R03AI185654
Award Date
5/31/24
Completion Date
3/31/26
Dollars Obligated
$261K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Johnson City, TN 37614, USA
Similar Awards
This Project Grant award of $868,776.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to characterize a novel post-transcriptional regulator in the opportunistic pathogen Pseudomonas aeruginosa. The key objectives are to: Identify the direct regulatory targets of the RNA-binding protein PhaF under standard lab conditions, infection-relevant conditions, and in clinical isolates to...
This $151,040 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the regulatory role of the small regulatory RNA BECO on essential virulence factors in the pathogen Pseudomonas aeruginosa. The research aims to determine how BECO controls the expression of the Type III Secretion System and pyochelin biosynthesis genes, which are critical for P....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program, provides $430,760 to the University of Pittsburgh to conduct research on improving host defense against the deadly Gram-negative bacterium, Pseudomonas aeruginosa. The key objectives are to: 1) Determine the role of the CXCR4 chemokine receptor and galectin-3 protein in the protective function of lung...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS), under CFDA 93.859 Biomedical Research and Research Training program, provides $361,297 to the University of Georgia Research Foundation to characterize the regulation of cell envelope biosynthesis in the bacterial pathogen Pseudomonas aeruginosa. The project aims to: (I) dissect the molecular basis of lipopolysaccharide (LPS) and peptidoglycan (PG) coordination and the physiological consequences of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $741,917 to West Virginia University Research Corporation to develop therapeutic antibodies for the treatment of multidrug-resistant Pseudomonas aeruginosa infections, with a focus on sepsis. The key objectives are to characterize the mechanism of action of a lead antibody candidate, formulate it into a multivalent...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is providing $239,348 to The Trustees of Columbia University in the City of New York to investigate the impact of regulatory T cells (Tregs) on host susceptibility to Pseudomonas aeruginosa infection. The key objectives are to evaluate whether Tregs protect against P. aeruginosa pneumonia by altering the airway...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $205,000 to The Trustees of Princeton University to conduct research examining the influence of chromosome copy number on Pseudomonas aeruginosa persisters to fluoroquinolone antibiotics. The research aims to fill knowledge gaps in understanding persistence to this antibiotic class in this opportunistic pathogen that...
This $849,713 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports research to elucidate RNA-RNA interaction networks during interbacterial interactions involving the bacterium Pseudomonas aeruginosa. The research team at Boston Children's Hospital seeks to define the small RNA (sRNA) interaction network in P. aeruginosa and decode the regulatory roles played by sRNAs during its interactions with other bacteria. The project will...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides $261,846 to New York Medical College to develop an intranasal vaccine against Pseudomonas aeruginosa (PA), a common cause of healthcare-associated infections. The research aims to create a multi-valent vaccine using tobacco mosaic virus as a delivery platform, with the goal of providing broad protection against different...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $439,896 to William Marsh Rice University to conduct research on developing pyocin-based treatments for multidrug-resistant Pseudomonas aeruginosa infections. The key objectives are to: 1) Comprehensively evaluate a panel of R pyocins from different subtypes to identify those with the widest killing spectrum against P....